ReviewFrontiers in pharmacology2022

PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies.

Nannan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.